Navigation Links
Moral philosopher questions memory manipulation
Date:4/29/2008

Is medicated memory manipulation ethically sound? And perhaps more importantly, who should be charged with the decision to deliver such a treatment: patient or physician?

Elisa Hurley, a philosophy professor, is seeking answers to these questions in her research currently underway at The University of Western Ontario.

In the Academy Award-winning film Eternal Sunshine of the Spotless Mind, a fictional, non-surgical procedure called targeted memory erasure is used to delete painful memories the afflicted wish to forget permanently.

And while the storys science-fiction based concept earned the movie an Oscar for best original screenplay, real-life scientists are conducting clinical trials today using beta-blockers drugs traditionally used for varying heart conditions for manipulating the memories of people, who may go on to suffer from post-traumatic stress disorder (PTSD).

Hurley says while the real threat of developing PTSD might be a good enough reason to use beta-blockers as a preventative measure, she also wants policy makers to consider the ramifications of what such a treatment may mean to a persons moral well-being.

Beta-blockers do not cause amnesia. Rather they make memories less vivid, detailed and arousing, explains Hurley, who specializes in bioethics. They lessen the emotional impact when someone is recalling upsetting events.

Citing examples of a woman who has been brutally raped or a soldier who has killed while serving in the military, Hurley says, In types of trauma involving interpersonal violence, such as sexual violence, torture, combat stress, and genocide, emotional memories may play a crucial role in ones moral recovery.

With respect to the military case, she adds, I suggest that dampening emotional responses such as guilt, revulsion, and regret to someones participation in wrongdoing may undermine an appropriate understanding by the person of his or her moral responsibil
'/>"/>

Contact: Jeff Renaud
jrenaud9@uwo.ca
519-661-2111 x85165
University of Western Ontario
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Pelosi on Global HIV/AIDS Bill: There is a Moral Imperative to Combat This Epidemic
2. Vioxx Disclosure Emphasizes Need for New Web Resource that Answers Questions About Anti-Epileptic Medication Use
3. Susan G. Komen for the Cure Advocacy Alliance Suggests Questions for Tonights Presidential Debate
4. New conference tackles the tough questions in lung cancer
5. Study questions cost of complexity in evolution
6. Oregon study raises questions on synthetic progestins
7. American College of Pediatricians Questions Validity of Spanking Study
8. Report Lists Key Policy Questions Facing State, National Health Reform
9. Study raises questions about diagnosis, medical treatment of ADHD
10. Parents Face Tough Questions When Santas Magic Fades
11. 2008 Presidential Hopefuls Fail to Respond to Questions About Obesity in U.S.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... NH, 4/24/14) Dartmouth has been awarded one of ... serve as a Lead Academic Participating Site in its ... Award recipients are a select groups of investigators charged ... fewer cooperative groups., The NCTN grant system reflects recommendations ... It streamlines operations to achieve four goals:, ...
(Date:4/24/2014)... Orleans, LA The National Science Foundation has ... Research Experiences for Undergraduates (REU) Site grant in ... the training of undergraduates from diverse social and ... the New Orleans area. The project will ... the summers of 2014-16. It will be ...
(Date:4/24/2014)... research led by a scientist at the University of ... element in the development of the nervous system may ... breast cancer., A research team, led by Dr ... Department of Biology at York, has studied how voltage-gated ... These channels are found in the membranes of excitable ...
(Date:4/23/2014)... was safe and effective in treating patients with ... , according to a new pilot study published ... online. Known as fecal microbiota transplantation, the treatment ... or a nasogastric tube. The findings suggest approaches ... available to patients. , A growing concern, ...
(Date:4/23/2014)... Moffitt Cancer Center researchers say clinical trials for ... leukemia (AML) are very promising. Patients treated with ... and daunorubicin, are showing better responses than patients ... , "Acute myeloid leukemia is an aggressive ... success, especially in older patients," explained Jeffrey Lancet, ...
Breaking Medicine News(10 mins):Health News:Dartmouth awarded lead role in NCI clinical trials network 2Health News:Dartmouth awarded lead role in NCI clinical trials network 3Health News:Breast cancer replicates brain development process 2Health News:Pilot study suggests ways to widen access to fecal transplants for C. diff infections 2Health News:Moffitt Cancer Center's phase 3 study may be game-changer for acute myeloid leukemia 2
... Elsevier announced today that major global ... Germany, has signed an agreement to purchase EMBASE ... first time, EMBASE Classic is a fully digitized ... Journals published between 1947 and 1973. Covering ...
... randomized, controlled, multi-center trial has found that cardiac ... uptake during exercise testing, the trial,s primary endpoint, ... mechanical problems that disrupt the heart,s normal rhythm ... on EKG. , The Resynchronization Therapy in Narrow ...
... OSTE ) announced today that third quarter 2007 revenue ... revenue of $23.4,million. Revenue from Osteotech,s "core" DBM and ... months ended September 30,2007 as compared to revenue of ... of 2006. Gross margin improved to 55% in the ...
... Nov. 6 EntreMed, Inc.,(Nasdaq: ENMD ), ... of cancer and inflammatory diseases, today,reported results for ... (Logo: http://www.newscom.com/cgi-bin/prnh/20010620/ENMDLOGO ) Revenues ... $3,023,000 for the comparable period a year ago. ...
... (Pink Sheets: BIEL), announced today that Michael Seidenman,R. ... President of Sales. Mr. Seidenman is a ... versed in electro medicine devices. He brings to,the ... sales,management. Mr. Seidenman has launched many new products, ...
... Nov. 6 /PRNewswire-FirstCall/ - Response Biomedical,Corporation (TSX-V: RBM, ... Stock Exchange (TSX) has conditionally approved the Company,s,application ... Listing on the TSX,will be subject to the ... Company will issue a news release when final ...
Cached Medicine News:Health News:EMBASE Classic makes inroads into pharmaceutical industry 2Health News:Study puts brakes on extending indications for cardiac resynchronization therapy 2Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 2Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 3Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 4Health News:Osteotech Reports 2007 Third Quarter Financial Results; Core Segment Revenue Increased 28%; Gross Margin Improved to 55%; Diluted Earnings Per Share of $.09 5Health News:EntreMed Reports Third Quarter 2007 Financial Results 2Health News:EntreMed Reports Third Quarter 2007 Financial Results 3Health News:EntreMed Reports Third Quarter 2007 Financial Results 4Health News:EntreMed Reports Third Quarter 2007 Financial Results 5Health News:BioElectronics Corporation Announces Addition of Michael Seidenman, R.Ph. as Vice President of Sales 2Health News:Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 2Health News:Response Biomedical Corporation Receives Conditional Listing Approval from the Toronto Stock Exchange 3
(Date:1/15/2014)... , Jan. 15, 2014  Research and Markets ( http://www.researchandmarkets.com/research/6k27gw/dental ... Consumables Market - Global Industry Analysis, Size, Share, Growth, ... their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ... are used on patients in order to treat dental ...
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb ... in ambulances and other transport vehicles, an advanced and portable UV ... personnel for the first time. In order to ... these deadly pathogens, West Palm Beach Fire ...
Breaking Medicine Technology:Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 2Dental Consumables Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2018 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2
... and GAITHERSBURG, Md., May 30, 2012   Life Technologies ... OpGen, Inc ., a commercial stage whole genome analysis ... agreement to develop systems, technologies and applications intended to ... the public health and infectious disease markets. ...
... of Opioid Management is presenting the ... the Joseph B. Martin Conference Center at Harvard Medical School. ... clinical application, and compliance, will address the proper use, and ... According to a recent National Survey on Drug Use and ...
Cached Medicine Technology:Life Technologies and OpGen Sign Collaborative Agreement to Leverage Ion Torrent and Whole Genome Mapping Technologies 2Life Technologies and OpGen Sign Collaborative Agreement to Leverage Ion Torrent and Whole Genome Mapping Technologies 3Life Technologies and OpGen Sign Collaborative Agreement to Leverage Ion Torrent and Whole Genome Mapping Technologies 4Unique Conference Tackles Opioid Abuse Epidemic 2
... offers state-of-the-art quality in an instrument of ... durability. Low profile cutting tips allow access ... I instruments are available in just about ... required for large and small joint arthroscopic ...
... Instrument program offers state-of-the-art quality in an ... strength and durability. Low profile cutting tips ... spaces. Series I instruments are available in ... and angle required for large and small ...
... Series I Instrument program offers state-of-the-art quality ... while maintaining strength and durability. Low profile ... tight joint spaces. Series I instruments are ... style, size and angle required for large ...
... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ... angle required for large and small joint ...
Medicine Products: